Blog

CMS is accelerating its move from process-heavy Star measures to outcomes that reflect real improvements in member health.  MA plans

For plan year 2026, Medicare Advantage has experienced significant disruption as plan offerings have shrunk and enrollment shifts have accelerated.

Improving quality outcomes isn’t about doing more outreach—it’s about doing the right outreach, in the right order, to the right person.  Across medication

Each year, we all like to pause and reflect—not just on where our industry has been, but on where it’s

Medicare Advantage (MA) plans are feeling the ripple effects of a changing Star Ratings landscape. Fewer plans are earning 4-5

According to Q2 2025 earnings data, Medicare Advantage (MA) is facing notable pressure. Between challenges such as the rollout of

Following last week’s PQA Convenes panel discussion—where AdhereHealth CEO Kempton Presley joined industry leaders to explore “AI in Practice Today:

Imagine being elderly, juggling prescriptions from three different specialists, and trying to remember whether the blue pill should be taken

Medication safety has become an urgent priority as Medicare Advantage members increasingly rely on prescription drugs to manage chronic conditions.

Beginning in MY 2026, CMS is introducing sociodemographic status (SDS) risk adjustment into the three cornerstone Part D adherence measures:

In the world of Medicare Advantage (MA), medication adherence is the workhorse for strong Star Ratings performance. It’s closely tied

As healthcare continues to shift toward value-based care, Pharmacy Benefit Managers (PBMs), Managed Care Organizations (MCOs) and health systems face